Literature DB >> 6779306

Inhibition of 5-hydroxytryptamine and noradrenaline uptake in platelets and synaptosomes incubated in plasma from human subjects treated with amitryptyline or nortriptyline: utilization of the principle for a bioassay method.

J Tuomisto, E Tukiainen, R Voutilainen, P Tuomainen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6779306     DOI： 10.1007/bf00427639

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  13 in total

1.  Plasma nortriptyline and clinical response.

Authors:  G Burrows; B A Scoggins; L R Turecek; B Davies
Journal:  Clin Pharmacol Ther       Date:  1974-10       Impact factor: 6.875

2.  The human platelet as a pharmacologic model for the adrenergic neuron. The uptake and release of norepinephrine.

Authors:  W B Abrams; H M Solomon
Journal:  Clin Pharmacol Ther       Date:  1969 Sep-Oct       Impact factor: 6.875

3.  Gas chromatography-mass spectrometry of nortriptyline in body fluids of man.

Authors:  C G Hammar; B Alexanderson; B Holmstedt; F Sjöqvist
Journal:  Clin Pharmacol Ther       Date:  1971 May-Jun       Impact factor: 6.875

4.  Pharmacological and biochemical studies with three metabolites of nomifensine.

Authors:  H Kruse; I Hoffmann; H J Gerhards; M Leven; U Schacht
Journal:  Psychopharmacology (Berl)       Date:  1977-01-31       Impact factor: 4.530

5.  Hydroxylated metabolites of tricyclic antidepressants: preclinical assessment of activity.

Authors:  W Z Potter; H M Calil; A A Manian; A P Zavadil; F K Goodwin
Journal:  Biol Psychiatry       Date:  1979-08       Impact factor: 13.382

6.  Decreased uptake of 5-hydroxytryptamine in blood platelets from patients with endogenous depression.

Authors:  J Tuomisto; E Tukiainen; U G Ahlfors
Journal:  Psychopharmacology (Berl)       Date:  1979-10       Impact factor: 4.530

7.  No circadian effect on nortriptyline kinetics in man.

Authors:  S Nakano; L E Hollister
Journal:  Clin Pharmacol Ther       Date:  1978-02       Impact factor: 6.875

8.  5-Hydroxytryptamine and dopamine transport by rat and human blood platelets.

Authors:  J L Gordon; H J Olverman
Journal:  Br J Pharmacol       Date:  1978-02       Impact factor: 8.739

9.  Inhibition of biogenic amines uptake by imipramine, desipramine, 2 OH-imipramine and 2 OH-desipramine in rat brain.

Authors:  J I Javaid; J M Perel; J M Davis
Journal:  Life Sci       Date:  1979-01-01       Impact factor: 5.037

10.  The uptake of adrenaline and noradrenaline by blood platelets of the pig.

Authors:  G V BORN; O HORNYKIEWICZ; A STAFFORD
Journal:  Br J Pharmacol Chemother       Date:  1958-12
View more
  5 in total

1.  Platelets and biogenic amines. 2. Indications for a discrete low affinity uptake mechanism shared by norepinephrine and 5-hydroxytryptamine in human platelets.

Authors:  R Malmgren
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Serotonin uptake inhibition during treatment of depression with nortriptyline caused by parent drug and not by 10-hydroxymetabolites.

Authors:  R Malmgren; A Aberg-Wistedt; L Bertilsson
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  Effect on radiolabelled-monoamine uptake in vitro of plasma taken from healthy volunteers administered the antidepressant sibutramine HCl.

Authors:  G P Luscombe; N A Slater; M B Lyons; R D Wynne; M L Scheinbaum; W R Buckett
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  Effects of zimeldine, mianserin and amitriptyline on psychomotor skills and their interaction with ethanol a placebo controlled cross-over study.

Authors:  T Seppälä; C Strömberg; I Bergman
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  Inhibitors of serotonin and noradrenaline uptake in human plasma after withdrawal of zimelidine and clomipramine treatment.

Authors:  S B Ross; A Aberg-Wistedt
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.